Generic, Branded Generic & Proprietary Medicinal Products - Group 13
Estimated value
—
goods
Awarded value
—
Suppliers
25
7 SME
Lots
1
25 awarded
Published
14 Feb 2024
Description
Generic, Branded Generic & Proprietary Medicinal Products - Group 13 (4844244)
Scope
- Reference
- 4844244
- Commercial tool
- Standalone contract
- Contract dates
It is likely that most contracts awarded using the DPS will be renewed for purposes of continued supply. The product range of each contract may, however, change on each renewal. Some contracts may be restructured, merged, divided or no longer required.
- Main category
- goods
- Contract locations
- Northern Ireland
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Compliance with Contract Scope and Specification | Pass/Fail | quality | — |
| Supply and Delivery of Product/Evidence of compliance with Good Distribution Practice (GDP) requirements | Pass/Fail | quality | — |
| Supply and Delivery of Product Same Working Day Delivery | 5% | quality | — |
| Supply and Delivery of Product Wholesale Distribution | 5% | quality | — |
| Continuity of Supply Minimum Committed Stockholding | 8% | quality | — |
| Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA): Section 1 | Pass/Fail | quality | — |
| Governance, Quality Control and Risk Pharmaceutical Quality Assessment (PQA): Section 2 - Section 6 (inclusive) | 40% | quality | — |
| — | 42% | price | — |
Submission & procedure
- Procedure
- Restricted procedure
Award details· 25 awards
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—
Awarded to
AL
CH 08004972
AU
CH 00079585
AP
CH 11316999
AP
CH 01535640
BI
CH 06204088
CL
CH 02140985
FA
CH 11368401
FK
CH 02182135
GP
CH 11829209
JC
CH 01027904
MP
CH 00620024
MP
CH 02619880
NH
CH 06844351
NU
CH 10918621
PL
CH 00526209
RP
CH 00924648
SL
CH 01547204
WU
CH 05835570